SGCB and neoplasm: Collectively, the data demonstrated that sGC deletion decreased TGFβ1 expression in the vascular niche, consequently reprogrammed adjacent CAFs into CD105neg apCAFs, potentially contributing to the observed phenotype of reduced tumor growth.